These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 32982967)

  • 1. Cancer Stem Cells in Thyroid Tumors: From the Origin to Metastasis.
    Veschi V; Verona F; Lo Iacono M; D'Accardo C; Porcelli G; Turdo A; Gaggianesi M; Forte S; Giuffrida D; Memeo L; Todaro M
    Front Endocrinol (Lausanne); 2020; 11():566. PubMed ID: 32982967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered Epigenetic Mechanisms in Thyroid Cancer Subtypes.
    Zarkesh M; Zadeh-Vakili A; Azizi F; Foroughi F; Akhavan MM; Hedayati M
    Mol Diagn Ther; 2018 Feb; 22(1):41-56. PubMed ID: 28986854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial-to-mesenchymal transition in thyroid cancer: a comprehensive review.
    Shakib H; Rajabi S; Dehghan MH; Mashayekhi FJ; Safari-Alighiarloo N; Hedayati M
    Endocrine; 2019 Dec; 66(3):435-455. PubMed ID: 31378850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epigenetic landscape of differentiated thyroid cancer.
    Asa SL; Ezzat S
    Mol Cell Endocrinol; 2018 Jul; 469():3-10. PubMed ID: 28711609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms in differentiated thyroid cancer.
    Xie J; Fan Y; Zhang X
    Front Biosci (Landmark Ed); 2016 Jan; 21(1):119-29. PubMed ID: 26709764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated Analysis of Thyroid Cancer Public Datasets Reveals Role of Post-Transcriptional Regulation on Tumor Progression by Targeting of Immune System Mediators.
    Geraldo MV; Kimura ET
    PLoS One; 2015; 10(11):e0141726. PubMed ID: 26536459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation profiling of well-differentiated thyroid cancer uncovers markers of recurrence free survival.
    Mancikova V; Buj R; Castelblanco E; Inglada-Pérez L; Diez A; de Cubas AA; Curras-Freixes M; Maravall FX; Mauricio D; Matias-Guiu X; Puig-Domingo M; Capel I; Bella MR; Lerma E; Castella E; Reverter JL; Peinado MÁ; Jorda M; Robledo M
    Int J Cancer; 2014 Aug; 135(3):598-610. PubMed ID: 24382797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic alterations involved in cancer stem cell reprogramming.
    Muñoz P; Iliou MS; Esteller M
    Mol Oncol; 2012 Dec; 6(6):620-36. PubMed ID: 23141800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation signatures identify biologically distinct thyroid cancer subtypes.
    Rodríguez-Rodero S; Fernández AF; Fernández-Morera JL; Castro-Santos P; Bayon GF; Ferrero C; Urdinguio RG; Gonzalez-Marquez R; Suarez C; Fernández-Vega I; Fresno Forcelledo MF; Martínez-Camblor P; Mancikova V; Castelblanco E; Perez M; Marrón PI; Mendiola M; Hardisson D; Santisteban P; Riesco-Eizaguirre G; Matías-Guiu X; Carnero A; Robledo M; Delgado-Álvarez E; Menéndez-Torre E; Fraga MF
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2811-21. PubMed ID: 23666970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression.
    Huang Y; Yu S; Cao S; Yin Y; Hong S; Guan H; Li Y; Xiao H
    Thyroid; 2018 Sep; 28(9):1162-1173. PubMed ID: 29882471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of cell-type-specific methylation at the Maspin gene promoter is frequently involved in undifferentiated thyroid cancers.
    Ogasawara S; Maesawa C; Yamamoto M; Akiyama Y; Wada K; Fujisawa K; Higuchi T; Tomisawa Y; Sato N; Endo S; Saito K; Masuda T
    Oncogene; 2004 Feb; 23(5):1117-24. PubMed ID: 14743202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene methylation in thyroid tumorigenesis.
    Xing M
    Endocrinology; 2007 Mar; 148(3):948-53. PubMed ID: 16946009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like state.
    Lim YY; Wright JA; Attema JL; Gregory PA; Bert AG; Smith E; Thomas D; Lopez AF; Drew PA; Khew-Goodall Y; Goodall GJ
    J Cell Sci; 2013 May; 126(Pt 10):2256-66. PubMed ID: 23525011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal vs cancer thyroid stem cells: the road to transformation.
    Zane M; Scavo E; Catalano V; Bonanno M; Todaro M; De Maria R; Stassi G
    Oncogene; 2016 Feb; 35(7):805-15. PubMed ID: 25961919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plitidepsin has a cytostatic effect in human undifferentiated (anaplastic) thyroid carcinoma.
    Bravo SB; García-Rendueles ME; Seoane R; Dosil V; Cameselle-Teijeiro J; López-Lázaro L; Zalvide J; Barreiro F; Pombo CM; Alvarez CV
    Clin Cancer Res; 2005 Nov; 11(21):7664-73. PubMed ID: 16278386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid Carcinoma: Phenotypic Features, Underlying Biology and Potential Relevance for Targeting Therapy.
    Hu J; Yuan IJ; Mirshahidi S; Simental A; Lee SC; Yuan X
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor β upregulated by lncRNA-H19 to promote cancer stem-like properties in papillary thyroid carcinoma.
    Li M; Chai HF; Peng F; Meng YT; Zhang LZ; Zhang L; Zou H; Liang QL; Li MM; Mao KG; Sun DX; Tong MY; Deng ZQ; Hou ZJ; Zhao Y; Li J; Wang XC; Lv SS; Zhang QQ; Yu X; Lam EW; Liu Q; Cui XN; Xu J
    Cell Death Dis; 2018 Nov; 9(11):1120. PubMed ID: 30389909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cancer stem cell markers is more frequent in anaplastic thyroid carcinoma compared to papillary thyroid carcinoma and is related to adverse clinical outcome.
    Yun JY; Kim YA; Choe JY; Min H; Lee KS; Jung Y; Oh S; Kim JE
    J Clin Pathol; 2014 Feb; 67(2):125-33. PubMed ID: 23986551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of microRNAs in endocrine cancer metastasis.
    Lima CR; Gomes CC; Santos MF
    Mol Cell Endocrinol; 2017 Nov; 456():62-75. PubMed ID: 28322989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly Concordant Key Genetic Alterations in Primary Tumors and Matched Distant Metastases in Differentiated Thyroid Cancer.
    Sohn SY; Park WY; Shin HT; Bae JS; Ki CS; Oh YL; Kim SW; Chung JH
    Thyroid; 2016 May; 26(5):672-82. PubMed ID: 26971368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.